Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway

Anlotinib has strong antiangiogenic effects and leads to vessel normalization. However, the "window period" characteristic in regulating vessel normalization by anlotinib cannot fully explain the long-term survival benefits achieved through combining it with other drugs. In this study, thr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuedan Han (Author), Jialei Liu (Author), Yidong Zhang (Author), Eric Tse (Author), Qiyi Yu (Author), Yu Lu (Author), Yi Ma (Author), Lufeng Zheng (Author)
Format: Book
Published: Elsevier, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available